IXICO (LSE:IXI) Additional Paid-In Capital : £92.26 Mil(As of Sep. 2023)

View and export this data going back to 1996. Start your Free Trial

What is IXICO Additional Paid-In Capital?

IXICO's quarterly additional paid-in capital stayed the same from Sep. 2022 (£92.26 Mil) to Mar. 2023 (£92.26 Mil) and stayed the same from Mar. 2023 (£92.26 Mil) to Sep. 2023 (£92.26 Mil).

IXICO's annual additional paid-in capital stayed the same from Sep. 2021 (£92.26 Mil) to Sep. 2022 (£92.26 Mil) and stayed the same from Sep. 2022 (£92.26 Mil) to Sep. 2023 (£92.26 Mil).

IXICO Additional Paid-In Capital Historical Data

The historical data trend for IXICO's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IXICO Additional Paid-In Capital Chart

IXICO Annual Data

Trend

Sep13

Sep15

Sep16

Sep17

Sep18

Sep19

Sep20

Sep21

Sep22

Sep23

Additional Paid-In Capital

Get a 7-Day Free Trial

91.89

91.96

92.26

IXICO Semi-Annual Data
	Sep13	Mar14	Mar15	Sep15	Mar16	Sep16	Mar17	Sep17	Mar18	Sep18	Mar19	Sep19	Mar20	Sep20	Mar21	Sep21	Mar22	Sep22	Mar23	Sep23
Additional Paid-In Capital	Get a 7-Day Free Trial															92.26	92.26	92.26	92.26	92.26

IXICO Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

IXICO Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of IXICO's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

IXICO (LSE:IXI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IXICO PLC (LSE:IXI) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

PHYOF:USA

Address

15 Long Lane, 4th Floor, Griffin Court, London, GBR, EC1A 9PN

Website

https://www.ixico.com

IXICO PLC is a UK-based company engaged in providing clinical trial services and technology to evaluate imaging endpoints to pharmaceutical companies. Its therapeutic areas include Alzheimer's, Parkinson's, Huntington's, Multiple Sclerosis, Progressive Supranuclear Palsy, and Other Rare Neurological Diseases. Services offered by the company are Early Phase Clinical Development, Late Phase Clinical Development, Post-Marketing, and Consultancy. The company's geographical segments include the United States, Switzerland, the United Kingdom, the Netherlands, Ireland and other- Europe. The Company work with healthcare organizations across the entire clinical research journey, for drug development analytics, medical imaging operations and post-marketing surveillance.

IXICO (LSE:IXI) Headlines

No Headlines